The drug “tranq” is causing problems in the major cities of the United States. This substance contains a sedative for animals and the effects are devastating. It is known that it first appeared in Philadelphia, but now it is causing alarm in California, where four deaths from consumption have already been recorded in recent months.
take it easy is a combination of fentanyl And xylazine, a sedative only approved for veterinary use in the United States, especially in horses.
It is known as the drug that turns people into zombies because it causes excessive drowsiness and respiratory depression, another consequence is its ability to rot the skin.
He Tranq causes excessive drowsiness, hypertension, tachycardia, respiratory depression and in general, consumers develop raw wounds in the soft tissues.
“I woke up in the morning crying because my arms were dying,” Tracy McCann told me The New York Times about the effects of tranq.
On the streets of Philadelphia – the ground zero of America’s opioid crisis – a new street drug baffles doctors.
—Sky News (@SkyNews) February 16, 2023
The drug, also known chill dope or zombie drug, was marketed for the first time Philadelphiabut it has spread everywhere USA and has caused a warning in California, San Francisco, Los Angeles and South Carolina. It is even feared that it has reached New York.
“They identified four overdose deaths, in which they found xylazinea veterinary sedative, in the toxicology of those people who died of a drug overdose other than fentanyl,” said Dr. Jeffrey Hom of the San Francisco Department of Public Health.
The xylazine It is normally only used to treat horses, and one of the most serious effects of long-term use in humans is the potential for serious injury and abscesses.
The U.S. Drug Enforcement Administration does not list xylazine as a banned substance.
Mabel is a talented author and journalist with a passion for all things technology. As an experienced writer for the 247 News Agency, she has established a reputation for her in-depth reporting and expert analysis on the latest developments in the tech industry.